| Patient Characteristics | Cohort name: flutamide alone |
|---|---|
| Number of patients, male | 33 |
| Number of patients, female | 0 |
| Stage | Non-metastatic castration resistant prostate cancer |
| Age: median | 71.8 years |
| Performance status: ECOG | 0: 33 1: 0 2: 0 3: 0 4: 0 |
| Patient Characteristics | Cohort name: flutamide + PROSTVAC |
| Number of patients, male | 31 |
| Number of patients, female | 0 |
| Stage | Non-metastatic castration resistant prostate cancer |
| Age: median | 69.8 years |
| Performance status: ECOG | 0: 31 1: 0 2: 0 3: 0 4: 0 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.